Male Factor Infertility Across India Using Aphrodite Criteria
APHR
Assessment of Male Factor Infertility Across India: An Observational Cross-Sectional Study Using the Aphrodite Criteria, a Hospital-based Study
1 other identifier
observational
1,090
1 country
1
Brief Summary
Study Purpose: The purpose of this study is to conduct an observational cross-sectional analysis of male factor infertility across diverse regions of India utilizing the Aphrodite Criteria. This novel patient classification system offers a systematic approach to describing and managing male infertility, particularly for hypogonadal males with idiopathic infertility. The study aims to evaluate the current state of male fertility across India and identify any regional variations in male reproductive health and hypogonadism, which may be influenced by environmental, lifestyle, and genetic factors. Study Objective: The primary objective of this study is to conduct an observational cross-sectional analysis of male factor infertility across various regions of India using the Aphrodite Criteria. To reveal the prevalence and determinants of male factor infertility across different regions of India. Hypothesis: We hypothesize that there are significant regional differences in male factor infertility characteristics across India, with variations in sperm quality and testicular function due to diverse environmental, lifestyle, and genetic factors. Additionally, we hypothesize that the application of the Aphrodite Criteria will provide a more detailed classification of male infertility compared to conventional semen analysis and that certain lifestyle factors such as smoking, obesity, and occupational exposures will be associated with poorer sperm quality and testicular function. Study Population: The study population will consist of male patients visiting clinics across different IVF centers in India. The total sample size includes subjects from five groups with the following distribution: 35 subjects in Group I ; 416 subjects in Group II; 270 subjects in Group III; 152 subjects in Group IV; 216 subjects in Group V The total sample size for all groups will be 1,090 subjects.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2026
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 28, 2025
CompletedFirst Posted
Study publicly available on registry
April 4, 2025
CompletedStudy Start
First participant enrolled
January 23, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 23, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 23, 2026
January 26, 2026
January 1, 2026
5 months
March 28, 2025
January 23, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Prevalence of male infertility across the country
Overall prevalence of male infertility according to the Aphrodite criteria in India.
6 months
Secondary Outcomes (2)
Prevalence of male infertility across various geographical distribution
6 months
Factors associated with male infertility
6 months
Study Arms (1)
Group 1
All the male population visiting IVF centre
Interventions
Eligibility Criteria
All male visiting IVF clinics across different centres
You may qualify if:
- All male visiting IVF clinic willingly giving consent for andrological evaluation.
You may not qualify if:
- NONE
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Indira IVF Hospital
Udaipur, Rajasthan, 313001, India
Related Publications (3)
Esteves SC, Yarali H, Vuong LN, Carvalho JF, Ozbek IY, Polat M, Le HL, Pham TD, Ho TM. Low Prognosis by the POSEIDON Criteria in Women Undergoing Assisted Reproductive Technology: A Multicenter and Multinational Prevalence Study of Over 13,000 Patients. Front Endocrinol (Lausanne). 2021 Mar 12;12:630550. doi: 10.3389/fendo.2021.630550. eCollection 2021.
PMID: 33790862RESULTMay WL, Johnson WD. A SAS macro for constructing simultaneous confidence intervals for multinomial proportions. Comput Methods Programs Biomed. 1997 Jul;53(3):153-62. doi: 10.1016/s0169-2607(97)01809-9.
PMID: 9230450RESULTEsteves SC, Humaidan P, Ubaldi FM, Alviggi C, Antonio L, Barratt CLR, Behre HM, Jorgensen N, Pacey AA, Simoni M, Santi D. APHRODITE criteria: addressing male patients with hypogonadism and/or infertility owing to altered idiopathic testicular function. Reprod Biomed Online. 2024 Apr;48(4):103647. doi: 10.1016/j.rbmo.2023.103647. Epub 2023 Oct 29.
PMID: 38367592RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chief Clinical Lab Operations
Study Record Dates
First Submitted
March 28, 2025
First Posted
April 4, 2025
Study Start
January 23, 2026
Primary Completion (Estimated)
June 23, 2026
Study Completion (Estimated)
October 23, 2026
Last Updated
January 26, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR
- Time Frame
- After publication of the study and on request
- Access Criteria
- Academic researchers, clinicians, and scientists involved in related fields of study. Regulatory Bodies: Organizations such as ethics committees, health authorities, and regulatory agencies that require access for monitoring and compliance purposes. Collaborators and Partners: Institutions or organizations collaborating on the study, subject to agreements for data sharing and confidentiality. What They Will Be Able to Access: Study Protocol: Complete details regarding the study design, objectives, and methodology. Statistical Analysis Plan (SAP): Full plan for data analysis, statistical methods, and handling of results. Informed Consent Form (ICF): Document outlining the consent process and participant rights, shared with participating researchers and ethics boards. Clinical Study Report (CSR): The final comprehensive report including all study findings, results, and conclusions. Analytic Code: The code used for statistical analysis, available for validation and reproducibility
The following supporting information will be made available as part of the data sharing plan: Study Protocol Available upon request or publication of study results. Statistical Analysis Plan (SAP) Will be shared with interested parties upon completion of the study. Informed Consent Form (ICF) A copy of the ICF will be available upon request from participating sites. Clinical Study Report (CSR) The final CSR will be shared once the study results are finalized and published. Analytic Code Will be shared alongside the study results for transparency and reproducibility of the findings.